Use of in Vitro Lipid Digestion Data to Explain the in Vivo Performance of Triglyceride-Based Oral Lipid Formulations of Poorly Water-Soluble Drugs: Studies with Halofantrine

Journal of Pharmaceutical Sciences

Volumn 93, Issue 5, 2004, Pages 1110-1121

  Porter, Christopher J H ^a   Kaukonen, Ann Marie ^a,c   Taillardat Bertschinger, Agnes ^a   Boyd, Ben J ^a   O'Connor, Jacquelyn M ^a   Edwards, Glenn A ^b   Charman, William N ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Absorption bioavailability; Lipid digestion; Lipid based drug delivery; Poorly water soluble drugs

Indexed keywords

HALOFANTRINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SOLUBILITY; LIPID HYDROLYSIS; LIPID SOLUBILITY; MALE; NONHUMAN;

EID: 1942498896     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20039     Document Type: Article

References (31)

1. Kaukonen AM, Boyd BJ, Porter CJH, Charman WN. 2004. Drug solubilization behaviour during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res 21:245-253.
2. Kaukonen AM, Boyd BJ, Charman WN, Porter CJH. 2004. Drug solubilization behaviour during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharm Res 21:254-260.
3. MacGregor KJ, Embleton JK, Lacy JE, Perry AP, Solomon LJ, Seager H, Pouton CW. 1997. Influence of lipolysis on drug absorption from the gastrointestinal tract. Adv Drug Del Rev 25:33-46.
4. Zangenberg NH, Mullertz A, Gjelstrup Kristensen H, Hovgaard L. 2001. A dynamic in vitro lipolysis model-II. Evaluation of the model. Eur J Pharm Sci 14:237-244.
5. Hernell O, Staggers JE, Carey MC. 1990. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry 29:2041-2056.
6. Staggers JE, Hernell O, Stafford RJ, Carey MC. 1990. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry 29:2028-2040.
7. Sek L, Porter CJH, Charman WN. 2001. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J Pharm Biomed Anal 25:651-661.
8. Sek L, Porter CJH, Kaukonen AM, Charman WN. 2002. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 54:29-41.
9. Zangenberg NH, Mullertz A, Gjelstrup Kristensen H, Hovgaard L. 2001. A dynamic in vitro lipolysis model-I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci 14: 115-122.
10. Humberstone AJ, Currie GJ, Porter CJH, Scanlon MJ, Charman WN. 1995. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. J Pharm Biomed Anal 13:265-272.
11. Humberstone AJ, Porter CJH, Charman WN. 1996. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine. J Pharm Sci 85:525-529.
12. Reymond J-P, Sucker H. 1988. In vitro model for ciclosporin intestinal absorption in lipid vehicles. Pharm Res 5:673-676.
13. Reymond J-P, Sucker H, Vonderscher J. 1988. In vivo model for ciclosporin intestinal absorption in lipid vehicles. Pharm Res 5:677-679.
14. Humberstone AJ, Charman WN. 1997. Lipid based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Del Rev 25:103-128.
15. Charman WN, Rogge MC, Boddy AW, Barr WH, Berger BM. 1993. Absorption of danazol after administration to different sites of the gastrointestinal tract and the relationship to single- and double-peak phenomena in the plasma profiles. J Clin Pharmacol 33:1207-1213.
16. Caliph SM, Charman WN, Porter CJH. 2000. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 89:1073-1084.
17. Khoo SM, Shackleford D, Porter CJH, Edwards GA, Charman WN. 2003. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit dose lipid-based formulation to fasted dogs. Pharm Res 20:1460-1465.
18. Kossena GK, Boyd BJ, Porter CJH, Charman WN. 2003. Separation and characterisation of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water soluble drugs. J Pharm Sci 92:634-648.
19. Armand M, Borel P, Pasquier B, Dubois C, Senft M, Andre M, Peyrot J, Salducci J, Lairon D. 1996. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 271:G172-G183.
20. Ladas SD, Isaacs PET, Murphy GM, Sladen GE. 1984. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. Gut 25:405-411.
21. Gallo-Torres HE, Ludorf J, Brin M. 1978. The effect of medium-chain triglycerides on the bioavailability of vitamin E. Int J Vit Nutr Res 48:240-241.
22. Myers RA, Stella VJ. 1992. Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int J Pharm 78:217-226.
23. Palin KJ, Wilson CG. 1984. The effect of different oils on the absorption of probucol in the rat. J Pharm Pharmacol 36:641-643.
24. Holmberg I, Aksnes L, Berlin T, Lindback B, Zemgals J, Lindeke B. 1990. Absorption of a pharmacological dose of vitamin D3 from two different lipid vehicles in man: Comparison of peanut oil and a medium chain triglyceride. Biopharm Drug Dispos 11:807-815.
25. Behrens D, Fricker R, Bodoky A, Drewe J, Heberer M. 1996. Comparison of cyclosporin A absorption from LCT and MCT solutions following intrajejunal administration in concious dog. J Pharm Sci 85: 666-668.
26. Porter CJH, Charman WN. 1996. Model systems for intestinal lymphatic transport studies. In: Borchardt RT, editor. Models for assessing drug absorption and metabolism. New York: Plenum Press. pp 85-102.
27. Kostewicz ES, Carlsson AS, Hanish G, Krumkuhler K, Nilsson RG, Löfgren L, Abrahamsson B. 2002. Comparison of dog and human intestinal fluid and its impact on solubility estimations. Eur J Pharm Sci 17:S111.
28. Bates TR, Carrigan PJ. 1975. Apparent absorption kinetics of micronized griseofulvin after its oral administration on single and multiple dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension. J Pharm Sci 64:1475-1481.
29. Carrigan PJ, Bates TR. 1973. Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat. J Pharm Sci 62:1476-1479.
30. Khoo SM, Prankerd RJ, Edwards GA, Porter CJH, Charman WN. 2002. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs. J Pharm Sci 91:647-659.
31. Taillardat-Bertschinger A, Perry CS, Galland A, Prankerd RJ, Charman WN. 2003. Partitioning of halofantrine hydrochloride between water, micellar solutions, and soybean oil: Effects on its apparent ionization constant. J Pharm Sci 92:2217-2228.